3.0T多体素1H-MRS在乳腺病变诊断中的附加价值
本研究前瞻性纳入49个≥8mm的增强乳腺病变行3.0T多体素1H-MRS,测量最高胆碱浓度并与组织病理对照,以>1.70mmol/L提示恶性,按<1cm与≥1cm分层分析。恶性病灶最高胆碱浓度中位1.73mmol/L,显著高于良性0.87mmol/L(p=0.02);≥1cm病灶敏感性70%、特异性93%、NPV89%。结论:MRS对≥1cm BI-RADS 3-5病变有较好附加诊断价值,小病灶效能不足。
要点
- 3.0T多体素1H-MRS以最高胆碱浓度>1.70mmol/L为阈值,≥1cm乳腺病变特异性93%、NPV89%。
- 恶性病灶最高胆碱浓度中位1.73mmol/L,良性0.87mmol/L,p=0.02。
- 对≥1cm良性增强病变,MRS可避免9例靶向超声、6例超声联合活检。
核心结论
- 3.0T多体素1H-MRS对≥1cm的BI-RADS 3-5乳腺病变良恶性鉴别具有较好诊断价值。
- 以最高胆碱浓度>1.70mmol/L为恶性阈值时,≥1cm病灶敏感性70%、特异性93%、NPV89%。
- 对小于1cm的乳腺病变,MRS诊断效能似乎不足。
研究设计与样本
- 前瞻性研究,连续纳入2017-2022年49个≥8mm的增强乳腺病变。
- 采用3.0T多体素质子1H-MRS计算每个病灶的最高胆碱浓度,并与组织病理亚型对照。
- 按病灶大小进行分层分析(<1cm与≥1cm)。
- 患者平均年龄41岁(范围23-71岁),49个病灶中17个为恶性。
关键影像表现/征象
- 恶性病灶最高胆碱浓度中位数为1.73mmol/L(±1.14,范围0.11-8.24),显著高于良性病灶0.87mmol/L(±0.84,范围0.09-6.37)(p=0.02)。
- 在≥1cm病灶(n=37)中仅发现3例假阴性和2例假阳性。
- 在≥1cm良性增强病灶中,MRS可避免9例靶向超声或6例超声联合活检。
诊断标准与关键数值
- 最高胆碱浓度>1.70mmol/L提示恶性。
- 全部49个病灶:AUC0.70(95%-CI 0.54-0.87),敏感性59%、特异性91%、NPV81%。
- ≥1cm病灶(n=37):敏感性70%、特异性93%、NPV89%。
临床应用与阅片要点
- 对≥1cm的BI-RADS 3-5乳腺病变,最高胆碱浓度>1.70mmol/L可支持恶性判断,但≥1cm病灶中仍有3例假阴性。
- 最高胆碱浓度较高的病灶应优先考虑恶性,良性病灶浓度通常较低。
- 对≥1cm良性增强病灶,MRS可减少9例靶向超声或6例超声联合活检,报告时可作为避免不必要操作的参考。
- 小于1cm病灶不宜单独依赖MRS作良恶性判断。
局限性
- 样本量有限(49个病灶)。
- 小于1cm乳腺病变中MRS效能似乎不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: To evaluate whether 3.0 T Multivoxel Proton Magnetic Resonance Spectroscopy (1H-MRS) can reliably and safely rule out malignancy in enhancing breast lesions with a size of at least 8 mm. Reducing the number of false positive (FP) MRI findings is essential to avoid unnecessary biopsies of benign lesions.
METHODS: This prospective study evaluated a consecutive series of 49 enhancing breast lesions ≥ 8 mm using multivoxel 1H-MRS (included 2017-2022). Each lesion's highest choline concentration was calculated and compared across histopathological subtypes. Stratified analysis was performed based on lesion size (<1 versus ≥ 1 cm). Highest choline concentration > 1.70 mmol/L was considered indicative of malignancy. ROC curves, sensitivity, specificity, negative predictive values (NPV), FP and false negative (FN) values were calculated.
RESULTS: Out of 49 lesions (in women with a mean age of 41, range 23-71), 17 were malignant. The median highest choline (mmol/L, ± IQR, range) was significantly higher in malignant lesions [1.73(±1.14, 0.11-8.24)] compared to benign lesions [0.87 (±0.84, 0.09-6.37)(p = 0.02)]. ROC curve showed an AUC of 0.70(95%-CI 0.54-0.87). Using a cut-off value of 1.70 mmol/L sensitivity was 59%, specificity 91%, and NPV 81% across all lesions. In lesions ≥ 1 cm (n = 37) only 3 FN and 2 FP cases were found, with a 70% sensitivity, 93% specificity and NPV of 89%. MRS could prevent target ultrasound (n = 9) or ultrasound plus biopsy (n = 6) in benign enhancing breast lesions ≥ 1 cm.
CONCLUSION: 3.0 T 1H-MRS shows promising diagnostic performance in differentiating malignant from benign BI-RADS 3-5 breast lesions ≥ 1 cm. In smaller breast lesions the performance of MRS seems insufficient.
引用
- Wielema, Pijnappel, De Bock, et al. The added value of 3.0 T quantitative multivoxel proton 1H-MR spectroscopy in the diagnostic work-up of breast lesions. Eur J Radiol. 2026. PMID: 42378809. doi:10.1016/j.ejrad.2026.113040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。